Sanofi’s Silvestri joins Ipsen as CMO

Sandra Silvestri will become EVP, CMO and head of global medical affairs, patient safety and patient affairs at Ipsen Group (Euronext:IPN; Pink:IPSEY) on May 5. Silvestri joins from Sanofi (Euronext:SAN; NASDAQ:SNY), where she was SVP and CMO of general medicine global business unit. She succeeds Steven Hildemann, who is leaving to pursue other opportunities.

Vanessa Malier disclosed in an email that she is leaving  Kurma Partners, where she has been managing partner since 2013. Malier helped to raise the European VC’s Biofund III. She did not disclose a new role...